IDO1 and melanoma: We performed HPLC-MS measurements of the IDO1 substrate tryptophan and its immunosuppressive product kynurenine in conditioned media of human melanoma cells (WM35) treated with either HPI-1, vismodegib or the IDO1-specific inhibitor epacadostat with or without IFNγ (Fig. 4A).